Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AD09	AVOCOM	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
R03DC03	AIRFAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	AIRFAST PEDIATRICS	G	Montelukast (sodium) - 4mg	4mg	Granules for solution	880,217 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,087,169 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,521,230 L.L
J01MA14	AVITAR 400	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	913,813 L.L
J01MA14	AVITAR 400	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	651,764 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	9,052,935 L.L
D06AX09	AVALON AVOBAN	G	Mupirocin - 2% w/w	2%	Ointment	460,938 L.L
R05CB01	ACC LONG	G	N-acetylcysteine - 600mg, Vitamin C - 75mg	600mg	Tablet, effervescent	286,238 L.L
M01AE02	ANODYNE 500	G	Naproxen - 500mg	500mg	Suppository	342,680 L.L
N02BG06	ACUPAN	B	Nefopam HCl - 20mg	20mg	Injectable solution	365,525 L.L
C05A	ANTROLIN	B	Nifedipine - 0.3%, Lidocaine - 1.5%		Cream	1,333,092 L.L
L01XK52	AKEEGA	B	Niraparib - 100mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
L01XK52	AKEEGA	B	Niraparib - 50mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 10mg	10mg	Tablet, orally disintegrating	2,422,948 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 5mg	5mg	Tablet, orally disintegrating	1,463,444 L.L
A02BC01	ARAPRIDE	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	427,342 L.L
A02BC01	AXIPRON	G	Omeprazole - 20mg	20mg	Capsule	373,358 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
S01HA02	ANESTOCIL	B	Oxybuprocaine HCl (Benoxinate HCl) - 0.4%	0.4%	Drops solution	442,124 L.L
S01GA04	ALERJON	G	Oxymetazoline HCl -		Drops solution	528,130 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for dispersion	17,850,751 L.L
A04AA55	AKYNZEO	B	Palonosetron - 0.5mg, Netupitant - 300mg		Capsule, hard	7,364,372 L.L
A04AA05	ALOXI	B	Palonosetron HCl - 0.25mg/5ml	0.25mg/5ml	Injectable solution	3,656,595 L.L
N02BE01	ADOL	G	Paracetamol - 125mg	125mg	Suppository	107,507 L.L
N02BE01	ALGIVIC INFANT	G	Paracetamol - 125mg	125mg	Suppository	199,657 L.L
N02BE01	ADOL	G	Paracetamol - 250mg	250mg	Suppository	124,977 L.L
N02BE01	ALGIVIC	G	Paracetamol - 250mg	250mg	Suppository	215,015 L.L

...